ASH 2012 Report – New multiple myeloma drug shows promise in treating people with advanced disease
Therapy may be new option for hard-to-treat blood cancer.
Therapy may be new option for hard-to-treat blood cancer.
Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.
Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.
Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.
A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers.
COLUMBUS, Ohio – Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer – a discovery that could point the… read more.
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among patients with prostate cancer at 12 months post-treatment according to a… read more.
Research presented at the American Society for Cell Biology (ASCB) annual meeting, 15-19 December 2012, San Francisco.
by Bruce Sylvester – FDA Highlights – Treatment with denosumab decreases the number of tumor giant cells in patients with giant-cell tumor of the bone, and increases new… read more.
by Bruce Sylvester – taken from The Lancet – Radiotherapy given immediately after prostate removal surgery has a long-term benefit of preventing progression of the disease, researchers reported… read more.